SEC Comment Letter 0000000000-24-000102 to OSR Health, Inc. (OSRH)
OSR Health, Inc.
Date: Jan. 3, 2024 · CIK: 0001840425 · Accession: 0000000000-24-000102
AI Filing Summary & Sentiment
Show Raw Text
United States securities and exchange commission logo
January 3, 2024
Kuk Hyoun Hwang
Chief Executive Officer
Bellevue Life Sciences Acquisition Corp.
10900 NE 4th Street, Suite 2300
Bellevue, WA 98004
Re:Bellevue Life Sciences Acquisition Corp.
Draft Registration Statement on Form S-4
Submitted December 21, 2023
CIK No. 0001840425
Dear Kuk Hyoun Hwang:
Our initial review of your registration statement indicates that it fails in numerous
material respects to comply with the requirements of the Securities Act of 1933, the rules and
regulations thereunder and the requirements of the form. More specifically,
The independent auditors' report for OSR Holdings Co., Ltd. does not refer to conducting
the audit in accordance with the standards of the PCAOB.
We will provide more detailed comments relating to your registration statement
following our review of a substantive amendment that addresses these deficiencies.
Please contact Katherine Bagley at 202-551-2545 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Gary Kocher